Human Genome Epidemiology Literature Finder
|
Records 1 - 14 (of 14 Records) |
| Query Trace: Neoplasms and CBR3[original query] |
|---|
| Genotype of human carbonyl reductase CBR3 correlates with doxorubicin disposition and toxicity. Pharmacogenetics and genomics 2008 Jul 18 (7): 623-31. Fan L, Goh BC, Wong CI, Sukri N, Lim SE, Tan SH, Guo JY, Lim R, Yap HL, Khoo YM, Iau P, Lee HS, Lee SC |
| Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer. Cancer 2008 Jun 112 (12): 2789-95. Blanco Javier G, Leisenring Wendy M, Gonzalez-Covarrubias Vanessa M, Kawashima Toana I, Davies Stella M, Relling Mary V, Robison Leslie L, Sklar Charles A, Stovall Marilyn, Bhatia Smi |
| CBR1 and CBR3 pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients. Cancer science 2008 Oct 99 (10): 2045-54. Lal Suman, Sandanaraj Edwin, Wong Zee Wan, Ang Peter C S, Wong Nan Soon, Lee Edmund J D, Chowbay Balr |
| Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Aug 15 (16): 5258-66. Choi Ji-Yeob, Barlow William E, Albain Kathy S, Hong Chi-Chen, Blanco Javier G, Livingston Robert B, Davis Warren, Rae James M, Yeh I-Tien, Hutchins Laura F, Ravdin Peter M, Martino Silvana, Lyss Alan P, Osborne C Kent, Abeloff Martin D, Hayes Daniel F, Ambrosone Christine |
| Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Nov . Blanco JG, Sun CL, Landier W, Chen L, Esparza-Duran D, Leisenring W, Mays A, Friedman DL, Ginsberg JP, Hudson MM, Neglia JP, Oeffinger KC, Ritchey AK, Villaluna D, Relling MV, Bhatia S |
| Correlation of aldo-ketoreductase (AKR) 1C3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patients. British journal of clinical pharmacology 2013 Jun 75 (6): 1497-505. Voon Pei Jye, Yap Hui Ling, Ma Cho-Yee-Thu, Lu Fan, Wong Andrea L A, Sapari Nur Sabrina, Soong Richie, Soh Thomas I P, Goh Boon-Cher, Lee How-Sung, Lee Soo-Ch |
| Risk factors for anthracycline-associated cardiotoxicity. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2015 Nov . Reinbolt Raquel E, Patel Roshan, Pan Xueliang, Timmers Cynthia Dawn, Pilarski Robert, Shapiro Charles L, Lustberg Maryam |
| Evidence for association of SNPs in ABCB1 and CBR3, but not RAC2, NCF4, SLC28A3 or TOP2B, with chronic cardiotoxicity in a cohort of breast cancer patients treated with anthracyclines. Pharmacogenomics 2016 Jan . Hertz Daniel L, Caram Megan V, Kidwell Kelley M, Thibert Jacklyn N, Gersch Christina, Seewald Nicholas J, Smerage Jeffrey, Rubenfire Melvyn, Henry N Lynn, Cooney Kathleen A, Leja Monika, Griggs Jennifer J, Rae James |
Genome-wide association study of cardiotoxicity in the NCCTG N9831 (Alliance) adjuvant trastuzumab trial.
Pharmacogenetics and genomics 2017 Jul . Serie Daniel J, Crook Julia E, Necela Brian M, Dockter Travis J, Wang Xue, Asmann Yan W, Fairweather DeLisa, Bruno Katelyn A, Colon-Otero Gerardo, Perez Edith A, Thompson E Aubrey, Norton Nadi |
| NOS3 895G>T and CBR3 730G>A Are Associated with Recurrence Risk in Non-Muscle-Invasive Bladder Cancer with Intravesical Instillations of THP. Chemotherapy 2018 Aug 63 (4): 191-197. Zhou Qidong, Ding Weihong, Weng Yingjie, Ding Guanxiong, Xia Guowei, Xu Jianfeng, Xu Ke, Ding Qia |
| Impact of protocol change on individual factors related to course of adverse reactions to chemotherapy for breast cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2019 May . Paula Daniela Polessa, do Brasil Costa Vanessa I, Jorge Rosane V, Nobre Flávio |
| Association of genetic polymorphisms NCF4 rs1883112, CBR3 rs1056892, and ABCC1 rs3743527 with the cardiotoxic effects of doxorubicin in children with acute lymphoblastic leukemia. Pharmacogenetics and genomics 2021 Jul 31 (5): 108-115. Gándara-Mireles Jesús Alonso, Lares-Asseff Ismael, Reyes Espinoza Elio Aarón, Blanco Javier G, González Font Antonio Emilio, Córdova Hurtado Lourdes Patricia, Castañeda Verónica Loera, Fierro Ignacio Villanueva, Romero Leslie Patrón, Reyes Horacio Alman |
| CBR3 V244M is associated with LVEF reduction in breast cancer patients treated with doxorubicin. Cardio-oncology (London, England) 2021 May 7 (1): 17. Lang Jennifer K, Karthikeyan Badri, Quiñones-Lombraña Adolfo, Blair Rachael Hageman, Early Amy P, Levine Ellis G, Sharma Umesh C, Blanco Javier G, O'Connor Trac |
| Replication of genetic associations of chemotherapy-related cardiotoxicity in the adjuvant NSABP B-31 clinical trial. Frontiers in oncology 2023 6 13 1139347. Pooja P Advani, Kathryn J Ruddy, Joerg Herrmann, Jordan C Ray, Emily C Craver, Greg Yothers, Reena S Cecchini, Corey Lipchik, Huichen Feng, Priya Rastogi, Eleftherios P Mamounas, Sandra M Swain, Charles E Geyer, Norman Wolmark, Soonmyung Paik, Katherine L Pogue-Geile, Gerardo Colon-Otero, Edith A Perez, Nadine Nort |
- Page last reviewed:Feb 1, 2024
- Content source: